
Phase II randomized clinical trial of endosonography and PET/CT versus clinical assessment only for follow‐up after surgery for upper gastrointestinal cancer (EUFURO study)
Author(s) -
Bjerring O. S.,
Fristrup C. W.,
Pfeiffer P.,
Lundell L.,
Mortensen M. B.
Publication year - 2019
Publication title -
british journal of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.202
H-Index - 201
eISSN - 1365-2168
pISSN - 0007-1323
DOI - 10.1002/bjs.11290
Subject(s) - medicine , asymptomatic , clinical endpoint , clinical trial , surgery , randomized controlled trial , cancer , radiology
Upper gastrointestinal malignancies have a poor prognosis. There is no consensus on how patients should be followed after surgery. The authors hypothesized that a structured follow-up programme including endoscopic ultrasonography (EUS) and [ 18 F]fluorodeoxyglucose (FDG) PET/CT would detect cancer recurrences, leading to more patients being eligible for therapy.